Table of Contents Author Guidelines Submit a Manuscript
Malaria Research and Treatment
Volume 2011, Article ID 703730, 5 pages
Review Article

Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-Infected Individuals

1Infectious Diseases Institute and Infectious Diseases Network for Treatment and Research in Africa (INTERACT), Makerere University College of Health Sciences, P.O. Box 7061, Kampala, Uganda
2Department of Pharmacology and Therapeutics, Trinity College Dublin 2, Ireland
3Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3BX, UK
4International Health, Epidemiology en Social Medicine, Universiteit Antwerpen, Universiteitsplein 1, 2610 Antwerp, Belgium

Received 14 December 2010; Accepted 14 February 2011

Academic Editor: Neena Valecha

Copyright © 2011 Pauline Byakika-Kibwika et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [6 citations]

The following is the list of published articles that have cited the current article.

  • T. N. Kakuda, R. DeMasi, Y. van Delft, and P. Mohammed, “Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial,” Hiv Medicine, vol. 14, no. 7, pp. 421–429, 2013. View at Publisher · View at Google Scholar
  • Guido Calleri, Rosanna Balbiano, and Pietro Caramello, “Are artemisinin-based combination therapies effective against Plasmodium malariae?,” Journal Of Antimicrobial Chemotherapy, vol. 68, no. 6, pp. 1447–1448, 2013. View at Publisher · View at Google Scholar
  • Kay Seden, Saye H. Khoo, David Back, Pauline Byakika-Kibwika, Mohammed Lamorde, Mairin Ryan, and Concepta Merry, “Global patient safety and antiretroviral drugdrug interactions in the resource-limited setting,” Journal of Antimicrobial Chemotherapy, vol. 68, no. 1, pp. 1–3, 2013. View at Publisher · View at Google Scholar
  • Erick Kipkoech Rutto, Barasa Otsyula, Ben Estambale, Joshua Nyagol, Julius Oyugi, Samson Ndege, Noel Onyango, Andrew Obala, Chrispinus J Simiyu, Gye Boor, and Winfrida Chelangat Cheriro, “Effects of HIV-1 infection on malaria parasitemia in milo sub-location, western Kenya.,” BMC research notes, vol. 8, pp. 303, 2015. View at Publisher · View at Google Scholar
  • Tran Dang Nguyen, Piero Olliaro, Arjen M. Dondorp, J. Kevin Baird, Ha Minh Lam, Jeremy Farrar, Guy E. Thwaites, Nicholas J. White, and Maciej F. Boni, “Optimum population-level use of artemisinin combination therapies: a modelling study,” Lancet Global Health, vol. 3, no. 12, pp. E758–E766, 2015. View at Publisher · View at Google Scholar
  • Helen Byomire Ndagije, Victoria Nambasa, Leonard Manirakiza, Donna Kusemererwa, Dan Kajungu, Sten Olsson, and Niko Speybroeck, “The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up Study,” Drug Safety, 2018. View at Publisher · View at Google Scholar